Next-generation approaches to understand and combat the antibiotic resistome

Nature Reviews Microbiology

Volumn 15, Issue 7, 2017, Pages 422-434

  Crofts, Terence S ^a   Gasparrini, Andrew J ^a   Dantas, Gautam ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; DRUG MECHANISM; GENETIC RESISTANCE; HORIZONTAL GENE TRANSFER; HUMAN; METAGENOMICS; MICROBIAL COMMUNITY; NEXT GENERATION SEQUENCING; NONHUMAN; PATHOGENIC ESCHERICHIA COLI; PLASMID; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; BACTERIAL GENE; BACTERIUM; COMMUNICABLE DISEASES, EMERGING; DRUG EFFECTS; GENETICS; HIGH THROUGHPUT SEQUENCING; METAGENOME; MICROBIOLOGY; MULTIDRUG RESISTANCE; PHYLOGENY; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNICABLE DISEASES, EMERGING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; METAGENOME; METAGENOMICS; PHYLOGENY;

EID: 85017121755     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2017.28     Document Type: Review

References (140)

1. Walsh, C. T. & Wencewicz, T. A. Prospects for new antibiotics: a molecule-centered perspective. J. Antibiot. (Tokyo) 67, 7-22 (2014).
2. Aminov, R. I. A brief history of the antibiotic era: lessons learned and challenges for the future. Front. Microbiol. 1, 134 (2010).
3. Brown, E. D. & Wright, G. D. Antibacterial drug discovery in the resistance era. Nature 529, 336-343 (2016).
4. Van Boeckel, T. P. et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect. Dis. 14, 742-750 (2014).
5. Wright, P. M., Seiple, I. B. & Myers, A. G. The evolving role of chemical synthesis in antibacterial drug discovery. Angew. Chem. Int. Ed. Engl. 53, 8840-8869 (2014).
6. Walsh, C. Antibiotics: Actions, Origins, Resistance (ASM Press, 2003).
7. Tyndall, J. Observations on the optical deportment of the atmosphere in reference to the phenomena of putrefaction and infection. Br. Med. J. 1, 121-124 (1876).
8. D'Costa, V. M. et al. Antibiotic resistance is ancient. Nature 477, 457-461 (2011).
9. Bhullar, K. et al. Antibiotic resistance is prevalent in an isolated cave microbiome. PLoS ONE 7, e34953 (2012).
10. Clemente, J. C. et al. The microbiome of uncontacted Amerindians. Sci. Adv. 1, e1500183 (2015).
11. Wright, G. D. The antibiotic resistome: the nexus of chemical and genetic diversity. Nat. Rev. Microbiol. 5, 175-186 (2007).
12. D'Costa, V. M., McGrann, K. M., Hughes, D. W. & Wright, G. D. Sampling the antibiotic resistome. Science 311, 374-377 (2006).
13. Benveniste, R. & Davies, J. Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc. Natl Acad. Sci. USA 70, 2276-2280 (1973).
14. Forsberg, K. J. et al. The shared antibiotic resistome of soil bacteria and human pathogens. Science 337, 1107-1111 (2012).
15. Knapp, C. W., Dolfing, J., Ehlert, P. A. & Graham, D. W. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ. Sci. Technol. 44, 580-587 (2010).
16. O'Neill, J. Tackling drug-resistant infections globally: final report and recommendations. amr-review.org https://amr-review.org/sites/default/files/160518-Final%20paper-with%20cover.pdf (2016).
17. Lewis, K. Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12, 371-387 (2013).
18. Moore, A. M. et al. Pediatric fecal microbiota harbor diverse and novel antibiotic resistance genes. PLoS ONE 8, e78822 (2013).
19. Yim, G., Wang, H. H. & Davies, J. Antibiotics as signalling molecules. Phil. Trans. R. Soc. B 362, 1195-1200 (2007).
20. Gradmann, C. Re-inventing infectious disease: antibiotic resistance and drug development at the Bayer Company 1945-1980. Med. Hist. 60, 155-180 (2016).
21. Fleming, A. in Nobel Lectures: Physiology or Medicine 1942-1962 83-93 (Elsevier, 1964).
22. Abraham, E. P. & Chain, E. An enzyme from bacteria able to destroy penicillin. 1940. Rev. Infect. Dis. 10, 677-678 (1988).
23. Chambers, H. F. & Deleo, F. R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629-641 (2009).
24. Akiba, T., Koyama, K., Ishiki, Y., Kimura, S. & Fukushima, T. On the mechanism of the development of multiple-drug-resistant clones of Shigella. Jpn J. Microbiol. 4, 219-227 (1960).
25. Rappe, M. S. & Giovannoni, S. J. The uncultured microbial majority. Annu. Rev. Microbiol. 57, 369-394 (2003).
26. Anantharaman, K. et al. Thousands of microbial genomes shed light on interconnected biogeochemical processes in an aquifer system. Nat. Commun. 7, 13219 (2016).
27. Adu-Oppong, B., Gasparrini, A. J. & Dantas, G. Genomic and functional techniques to mine the microbiome for novel antimicrobials and antimicrobial resistance genes. Ann. NY Acad. Sci. 1388, 42-58 (2017).
28. Wetterstrand, K. A. DNA sequencing costs: data from the NHGRI Genome Sequencing Program (GSP). genome.gov www.genome.gov/sequencingcostsdata (2016).
29. UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 43, D204-D212 (2015).
30. Rondon, M. R. et al. Cloning the soil metagenome: a strategy for accessing the genetic and functional diversity of uncultured microorganisms. Appl. Environ. Microbiol. 66, 2541-2547 (2000).
31. Martinez, J. L. & Baquero, F. Mutation frequencies and antibiotic resistance. Antimicrob. Agents Chemother. 44, 1771-1777 (2000).
32. Pino, M., Power, P., Gutkind, G. & Di Conza, J. A. INQ 1, a chromosome-encoded AmpC β-lactamase from Inquilinus limosus. J. Antimicrob. Chemother. 69, 560-562 (2014).
33. McGrath, M., Gey van Pittius, N. C., van Helden, P. D., Warren, R. M. & Warner, D. F. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. J. Antimicrob. Chemother. 69, 292-302 (2014).
34. Martinez, J. L., Baquero, F. & Andersson, D. I. Predicting antibiotic resistance. Nat. Rev. Microbiol. 5, 958-965 (2007).
35. Martinez, J. L., Coque, T. M. & Baquero, F. What is a resistance gene? Ranking risk in resistomes. Nat. Rev. Microbiol. 13, 116-123 (2015).
36. Gibson, M. K. et al. Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome. Nat. Microbiol. 1, 16024 (2016).
37. Spanogiannopoulos, P., Waglechner, N., Koteva, K. & Wright, G. D. A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria. Proc. Natl Acad. Sci. USA 111, 7102-7107 (2014).
38. Torres-Cortes, G. et al. Characterization of novel antibiotic resistance genes identified by functional metagenomics on soil samples. Environ. Microbiol. 13, 1101-1114 (2011).
39. Forsberg, K. J., Patel, S., Wencewicz, T. A. & Dantas, G. The tetracycline destructases: a novel family of tetracycline-inactivating enzymes. Chem. Biol. 22, 888-897 (2015).
40. Riesenfeld, C. S., Goodman, R. M. & Handelsman, J. Uncultured soil bacteria are a reservoir of new antibiotic resistance genes. Environ. Microbiol. 6, 981-989 (2004).
41. Allen, H. K., Moe, L. A., Rodbumrer, J., Gaarder, A. & Handelsman, J. Functional metagenomics reveals diverse β-lactamases in a remote Alaskan soil. ISME J. 3, 243-251 (2009).
42. Lang, K. S. et al. Novel florfenicol and chloramphenicol resistance gene discovered in Alaskan soil by using functional metagenomics. Appl. Environ. Microbiol. 76, 5321-5326 (2010).
43. Perron, G. G. et al. Functional characterization of bacteria isolated from ancient arctic soil exposes diverse resistance mechanisms to modern antibiotics. PLoS ONE 10, e0069533 (2015).
44. Donato, J. J. et al. Metagenomic analysis of apple orchard soil reveals antibiotic resistance genes encoding predicted bifunctional proteins. Appl. Environ. Microbiol. 76, 4396-4401 (2010).
45. Tao, W., Lee, M. H., Wu, J., Kim, N. H. & Lee, S. W. Isolation and characterization of a family VII esterase derived from alluvial soil metagenomic library. J. Microbiol. 49, 178-185 (2011).
46. Tao, W. et al. Characterization of two metagenome-derived esterases that reactivate chloramphenicol by counteracting chloramphenicol acetyltransferase. J. Microbiol. Biotechnol. 21, 1203-1210 (2011).
47. Jeon, J. H. et al. Novel metagenome-derived carboxylesterase that hydrolyzes β-lactam antibiotics. Appl. Environ. Microbiol. 77, 7830-7836 (2011).
48. Forsberg, K. J. et al. Bacterial phylogeny structures soil resistomes across habitats. Nature 509, 612-616 (2014).
49. McGarvey, K. M., Queitsch, K. & Fields, S. Wide variation in antibiotic resistance proteins identified by functional metagenomic screening of a soil DNA library. Appl. Environ. Microbiol. 78, 1708-1714 (2012).
50. Liu, Y. Y. et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16, 161-168 (2016).
51. Carnevali, C. et al. Occurence of mcr 1 colistin-resistant Salmonella enterica isolates recovered from human and animals in Italy, 2012 to 2015. Antimicrob. Agents Chemother. 60, 7532-7534 (2016).
52. Ortega-Paredes, D., Barba, P. & Zurita, J. Colistin-resistant Escherichia coli clinical isolate harbouring the mcr 1 gene in Ecuador. Epidemiol. Infect. 144, 2967-2970 (2016).
53. Teo, J. Q. et al. mcr 1 in multidrug-resistant blaKPC-2 producing clinical Enterobacteriaceae isolates in Singapore. Antimicrob. Agents Chemother. 60, 6435-6437 (2016).
54. Fernandes, M. R. et al. First report of the globally disseminated IncX4 plasmid carrying the mcr 1 gene in a colistin-resistant Escherichia coli sequence type 101 isolate from a human infection in Brazil. Antimicrob. Agents Chemother. 60, 6415-6417 (2016).
55. Delgado-Blas, J. F., Ovejero, C. M., Abadia-Patino, L. & Gonzalez-Zorn, B. Coexistence of mcr 1 and blaNDM 1 in Escherichia coli from Venezuela. Antimicrob. Agents Chemother. 60, 6356-6358 (2016).
56. Kline, K. E. et al. Investigation of first identified mcr 1 gene in an isolate from a U.S. patient - Pennsylvania, 2016. MMWR Morb. Mortal. Wkly Rep. 65, 977-978 (2016).
57. Wong, S. C. et al. Colistin-resistant Enterobacteriaceae carrying the mcr 1 gene among patients in Hong Kong. Emerg. Infect. Dis. 22, 1667-1669 (2016).
58. Brauer, A. et al. Plasmid with colistin resistance gene mcr 1 in ESBL-producing Escherichia coli strains isolated from pig slurry in Estonia. Antimicrob. Agents Chemother. 60, 6933-6936 (2016).
59. von Wintersdorff, C. J. et al. Detection of the plasmid-mediated colistin-resistance gene mcr 1 in faecal metagenomes of Dutch travellers. J Antimicrob. Chemother. 71, 3416-3419 (2016).
60. Diaz-Torres, M. L. et al. Novel tetracycline resistance determinant from the oral metagenome. Antimicrob. Agents Chemother. 47, 1430-1432 (2003).
61. Diaz-Torres, M. L. et al. Determining the antibiotic resistance potential of the indigenous oral microbiota of humans using a metagenomic approach. FEMS Microbiol. Lett. 258, 257-262 (2006).
62. Sommer, M. O., Dantas, G. & Church, G. M. Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325, 1128-1131 (2009).
63. Cheng, G. et al. Functional screening of antibiotic resistance genes from human gut microbiota reveals a novel gene fusion. FEMS Microbiol. Lett. 336, 11-16 (2012).
64. Moore, A. M. et al. Gut resistome development in healthy twin pairs in the first year of life. Microbiome 3, 27 (2015).
65. Fouhy, F. et al. Identification of aminoglycoside and β-lactam resistance genes from within an infant gut functional metagenomic library. PLoS ONE 9, e108016 (2014).
66. Pehrsson, E. C. et al. Interconnected microbiomes and resistomes in low-income human habitats. Nature 533, 212-216 (2016).
67. Pal, C., Bengtsson-Palme, J., Kristiansson, E. & Larsson, D. G. The structure and diversity of human, animal and environmental resistomes. Microbiome 4, 54 (2016).
68. Gonzales, P. R. et al. Synergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA. Nat. Chem. Biol. 11, 855-861 (2015).
69. Baym, M., Stone, L. K. & Kishony, R. Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351, aad3292 (2016).
70. Stone, L. K. et al. Compounds that select against the tetracycline-resistance efflux pump. Nat. Chem. Biol. 12, 902-904 (2016).
71. Lomovskaya, O., Zgurskaya, H. I., Totrov, M. & Watkins, W. J. Waltzing transporters and 'the dance macabre' between humans and bacteria. Nat. Rev. Drug Discov. 6, 56-65 (2007).
72. Drawz, S. M., Papp-Wallace, K. M. & Bonomo, R. A. New β-lactamase inhibitors: a therapeutic renaissance in an MDR world. Antimicrob. Agents Chemother. 58, 1835-1846 (2014).
73. Wright, G. D. Antibiotic adjuvants: rescuing antibiotics from resistance. Trends Microbiol. 24, 862-871 (2016).
74. Palmer, A. C., Angelino, E. & Kishony, R. Chemical decay of an antibiotic inverts selection for resistance. Nat. Chem. Biol. 6, 105-107 (2010).
75. Ejim, L. et al. Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy. Nat. Chem. Biol. 7, 348-350 (2011).
76. Brown, D. Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void? Nat. Rev. Drug Discov. 14, 821-832 (2015).
77. Cox, G. et al. A common platform for antibiotic dereplication and adjuvant discovery. Cell Chem. Biol. 24, 98-109 (2017).
78. Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990).
79. Wallace, J. C., Port, J. A., Smith, M. N. & Faustman, E. M. FARME DB: a functional antibiotic resistance element database. Database (Oxford) 2017, baw165 (2017).
80. Liu, B. & Pop, M. ARDB - Antibiotic Resistance Genes Database. Nucleic Acids Res. 37, D443-D447 (2009).
81. McArthur, A. G. et al. The comprehensive antibiotic resistance database. Antimicrob. Agents Chemother. 57, 3348-3357 (2013).
82. Xavier, B. B. et al. Consolidating and exploring antibiotic resistance gene data resources. J. Clin. Microbiol. 54, 851-859 (2016).
83. Zankari, E. et al. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67, 2640-2644 (2012).
84. Gibson, M. K., Forsberg, K. J. & Dantas, G. Improved annotation of antibiotic resistance determinants reveals microbial resistomes cluster by ecology. ISME J. 9, 207-216 (2015).
85. Eddy, S. R. A new generation of homology search tools based on probabilistic inference. Genome Inform. 23, 205-211 (2009).
86. Pesesky, M. W. et al. Evaluation of machine learning and rules-based approaches for predicting antimicrobial resistance profiles in Gram-negative Bacilli from whole genome sequence data. Front. Microbiol. 7, 1887 (2016).
87. Boulund, F., Johnning, A., Pereira, M. B., Larsson, D. G. & Kristiansson, E. A novel method to discover fluoroquinolone antibiotic resistance (qnr) genes in fragmented nucleotide sequences. BMC Genomics 13, 695 (2012).
88. Flach, C. F., Boulund, F., Kristiansson, E. & Larsson, D. J. Functional verification of computationally predicted qnr genes. Ann. Clin. Microbiol. Antimicrob. 12, 34 (2013).
89. Bertelli, C. & Greub, G. Rapid bacterial genome sequencing: methods and applications in clinical microbiology. Clin. Microbiol. Infect. 19, 803-813 (2013).
90. Didelot, X., Bowden, R., Wilson, D. J., Peto, T. E. & Crook, D. W. Transforming clinical microbiology with bacterial genome sequencing. Nat. Rev. Genet. 13, 601-612 (2012).
91. Zumla, A. et al. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections - needs, advances, and future prospects. Lancet Infect. Dis. 14, 1123-1135 (2014).
92. Kothari, A., Morgan, M. & Haake, D. A. Emerging technologies for rapid identification of bloodstream pathogens. Clin. Infect. Dis. 59, 272-278 (2014).
93. Pulido, M. R., Garcia-Quintanilla, M., Martin-Pena, R., Cisneros, J. M. & McConnell, M. J. Progress on the development of rapid methods for antimicrobial susceptibility testing. J. Antimicrob. Chemother. 68, 2710-2717 (2013).
94. Bradley, P. et al. Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis. Nat. Commun. 6, 10063 (2015).
95. Du, H., Chen, L., Tang, Y. W. & Kreiswirth, B. N. Emergence of the mcr 1 colistin resistance gene in carbapenem-resistant Enterobacteriaceae. Lancet Infect. Dis. 16, 287-288 (2016).
96. Kasbekar, N. Tigecycline: a new glycylcycline antimicrobial agent. Am. J. Health Syst. Pharm. 63, 1235-1243 (2006).
97. Sun, Y. et al. The emergence of clinical resistance to tigecycline. Int. J. Antimicrob. Agents 41, 110-116 (2013).
98. Moore, I. F., Hughes, D. W. & Wright, G. D. Tigecycline is modified by the flavin-dependent monooxygenase TetX. Biochemistry 44, 11829-11835 (2005).
99. Deng, M. et al. Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital. Antimicrob. Agents Chemother. 58, 297-303 (2014).
100. Leski, T. A. et al. Multidrug-resistant tet(X)-containing hospital isolates in Sierra Leone. Int. J. Antimicrob. Agents 42, 83-86 (2013).
101. Sutcliffe, J. A., O'Brien, W., Fyfe, C. & Grossman, T. H. Antibacterial activity of eravacycline (TP-434), a novel fluorocycline, against hospital and community pathogens. Antimicrob. Agents Chemother. 57, 5548-5558 (2013).
102. Macone, A. B. et al. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline. Antimicrob. Agents Chemother. 58, 1127-1135 (2014).
103. Davies, J. & Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417-433 (2010).
104. Walsh, C. Molecular mechanisms that confer antibacterial drug resistance. Nature 406, 775-781 (2000).
105. Shaw, W. V. et al. Primary structure of a chloramphenicol acetyltransferase specified by R plasmids. Nature 282, 870-872 (1979).
106. Yang, W. et al. TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics. J. Biol. Chem. 279, 52346-52352 (2004).
107. Neu, H. C. Effect of β-lactamase location in Escherichia coli on penicillin synergy. Appl. Microbiol. 17, 783-786 (1969).
108. Bush, K. Bench-to-bedside review: the role of β-lactamases in antibiotic-resistant Gram-negative infections. Crit. Care 14, 224 (2010).
109. Courvalin, P. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42 (Suppl. 1), S25-S34 (2006).
110. Katayama, Y., Ito, T. & Hiramatsu, K. A new class of genetic element, Staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 44, 1549-1555 (2000).
111. Ogawa, W., Onishi, M., Ni, R., Tsuchiya, T. & Kuroda, T. Functional study of the novel multidrug efflux pump KexD from Klebsiella pneumoniae. Gene 498, 177-182 (2012).
112. Ruggerone, P., Murakami, S., Pos, K. M. & Vargiu, A. V. RND efflux pumps: structural information translated into function and inhibition mechanisms. Curr. Top. Med. Chem. 13, 3079-3100 (2013).
113. Hinchliffe, P., Symmons, M. F., Hughes, C. & Koronakis, V. Structure and operation of bacterial tripartite pumps. Annu. Rev. Microbiol. 67, 221-242 (2013).
114. Piddock, L. J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19, 382-402 (2006).
115. Roberts, M. C. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol. Rev. 19, 1-24 (1996).
116. Tamber, S. & Hancock, R. E. On the mechanism of solute uptake in Pseudomonas. Front. Biosci. 8, s472-s483 (2003).
117. Poulou, A. et al. Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant. J. Clin. Microbiol. 51, 3176-3182 (2013).
118. Babouee Flury, B. et al. Association of novel nonsynonymous single nucleotide polymorphisms in ampD with cephalosporin resistance and phylogenetic variations in ampC, ampR, ompF, and ompC in Enterobacter cloacae isolates that are highly resistant to carbapenems. Antimicrob. Agents Chemother. 60, 2383-2390 (2016).
119. Sanders, C. C. & Sanders, W. E. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible β-lactamases. Antimicrob. Agents Chemother. 15, 792-797 (1979).
120. Perez, F., Endimiani, A., Hujer, K. M. & Bonomo, R. A. The continuing challenge of ESBLs. Curr. Opin. Pharmacol. 7, 459-469 (2007).
121. Potter, R. F., D'Souza, A. W. & Dantas, G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist. Updat. 29, 30-46 (2016).
122. Yong, D. et al. Characterization of a new metallo-β-lactamase gene, blaNDM 1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53, 5046-5054 (2009).
123. Castanheira, M. et al. Early dissemination of NDM 1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob. Agents Chemother. 55, 1274-1278 (2011).
124. Kumarasamy, K. K. et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10, 597-602 (2010).
125. Yigit, H. et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45, 1151-1161 (2001).
126. Pesesky, M. W. et al. KPC and NDM-1 genes in related Enterobacteriaceae strains and plasmids from Pakistan and the United States. Emerg. Infect. Dis. 21, 1034-1037 (2015).
127. Poirel, L., Rodriguez-Martinez, J. M., Mammeri, H., Liard, A. & Nordmann, P. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob. Agents Chemother. 49, 3523-3525 (2005).
128. Allen, H. K. et al. Call of the wild: antibiotic resistance genes in natural environments. Nat. Rev. Microbiol. 8, 251-259 (2010).
129. Robicsek, A. et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12, 83-88 (2006).
130. Jacoby, G. A., Strahilevitz, J. & Hooper, D. C. Plasmid-mediated quinolone resistance. Microbiol. Spectr. http://dx.doi.org/10.1128/microbiolspec.PLAS-0006-2013 (2014).
131. Li, J. et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6, 589-601 (2006).
132. Zheng, B. et al. Coexistence of MCR-1 and NDM-1 in clinical Escherichia coli isolates. Clin. Infect. Dis. 63, 1393-1395 (2016).
133. Sun, J. et al. Co transfer of blaNDM 5 and mcr 1 by an IncX3-X4 hybrid plasmid in Escherichia coli. Nat. Microbiol. 1, 16176 (2016).
134. Lam, K. N., Cheng, J., Engel, K., Neufeld, J. D. & Charles, T. C. Current and future resources for functional metagenomics. Front. Microbiol. 6, 1196 (2015).
135. Pehrsson, E. C., Forsberg, K. J., Gibson, M. K., Ahmadi, S. & Dantas, G. Novel resistance functions uncovered using functional metagenomic investigations of resistance reservoirs. Front. Microbiol. 4, 145 (2013).
136. Craig, J. W., Chang, F. Y., Kim, J. H., Obiajulu, S. C. & Brady, S. F. Expanding small-molecule functional metagenomics through parallel screening of broad-host-range cosmid environmental DNA libraries in diverse proteobacteria. Appl. Environ. Microbiol. 76, 1633-1641 (2010).
137. Martinez, A. et al. Genetically modified bacterial strains and novel bacterial artificial chromosome shuttle vectors for constructing environmental libraries and detecting heterologous natural products in multiple expression hosts. Appl. Environ. Microbiol. 70, 2452-2463 (2004).
138. Stokes, J. M. et al. Cold stress makes Escherichia coli susceptible to glycopeptide antibiotics by altering outer membrane integrity. Cell Chem. Biol. 23, 267-277 (2016).
139. Liebl, W. et al. Alternative hosts for functional (meta)genome analysis. Appl. Microbiol. Biotechnol. 98, 8099-8109 (2014).
140. Siefert, J. L. Defining the mobilome. Methods Mol. Biol. 532, 13-27 (2009).